VeraChem’s development team present the VM2 protein-ligand binding free energy method at Janssen Pharmaceutical

April 28, 2016
Licensing, Presentations

VeraChem’s development team carry out a presentation of the VM2 protein-ligand binding free energy method at Janssen Pharmaceutical, and make agreement for trial usage of the VM2 software package.

+ Read More

VeraChem’s development team carry out presentation of the VM2 protein-ligand binding free energy method at Dart NeuroScience

April 27, 2016
Licensing, Presentations

VeraChem’s development team carry out a presentation of the VM2 protein-ligand binding free energy method at Dart NeuroScience LLC, and make agreement for trial usage of the VM2 software package.

+ Read More